MDM2 inhibition by nutlin-3 also dramatically sensitizes NB cells to chemotherapy-induced apoptotic cell death [98], and nutlin-3 can reverse P-glycoprotein-mediated multidrug resistance of NB cells regardless of TP53 mutation status [99]. The gene discussed is TP53; the disease is neuroblastoma.